NCT05028907View on ClinicalTrials.gov

Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

May 15, 2021

Study Completion Date

July 15, 2021

Conditions
Ophthalmopathy , Lacrimal System
Interventions
DRUG

5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline hydrochloride, 2 mg Hydroxypropyl Methyl Cellulose, 10 mg α-tocopherol acetate and 8 mg macrogol 400).

The patients were advised to apply the drops 5 times daily for the first week, three times daily for the next two weeks and one time daily for another one week. The patients were examined before treatment, one week, one month and three months later.

DRUG

sodium hyaluronate, polyethylene and propylene glycol based) three times daily for three months

The patients were advised to apply the drops 5 times daily for the first week, three times daily for the next two weeks and one time daily for another one week. The patients were examined before treatment, one week, one month and three months later.

Trial Locations (1)

82524

Sohag University, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT05028907 - Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis | Biotech Hunter | Biotech Hunter